guest ::
| Home > Publications Database > Perspective of elderly patients on chronic use of potentially inappropriate medication - Results of the qualitative CIM-TRIAD study. > print |
| Home > Publications Database > Perspective of elderly patients on chronic use of potentially inappropriate medication - Results of the qualitative CIM-TRIAD study. > print |
| 001 | 140211 | ||
| 005 | 20240321220751.0 | ||
| 024 | 7 | _ | |a 10.1371/journal.pone.0202068 |2 doi |
| 024 | 7 | _ | |a pmid:30231027 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC6145513 |2 pmc |
| 024 | 7 | _ | |a altmetric:50403882 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-06533 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Heser, Kathrin |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Perspective of elderly patients on chronic use of potentially inappropriate medication - Results of the qualitative CIM-TRIAD study. |
| 260 | _ | _ | |a San Francisco, California, US |c 2018 |b PLOS |
| 264 | _ | 1 | |3 online |2 Crossref |b Public Library of Science (PLoS) |c 2018-09-19 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1602585381_27777 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Although potentially inappropriate medication (PIM) is associated with risk of harm due to adverse effects, it is frequently prescribed for elderly patients. The aim of this qualitative multi-center study was to gain insight into contextual factors that might lead to chronic PIM use. We conducted semi-structured interviews with elderly patients with or without chronic PIM use (patient interviews: n = 52). Patients were between 86 and 96 years old. The participants were recruited from the AgeCoDe study. Interviews were audiotaped and transcribed verbatim. The transcripts of the interviews were analysed using qualitative content analysis. Deductive and inductive categories were determined. We found contextual factors related to the patient and related to patient-general practitioner (GP) communication that might lead to chronic PIM use (i.e., positive features of PIM, maintaining characteristics of medication intake, barriers to deprescribe PIM, external actors supporting PIM intake, system-related factors). Besides certain health-related behaviours (e.g., own obligation to report to GP) and medication-related attitudes and knowledge (e.g., awareness of side effects and interaction of medicines), patient-GP-interactions that were characterised by mutual agreements on drugs (e.g., concerning dosage or discontinuation of a drug) might be advantageous to reduce the probability of chronic PIM use. The results might assist in the development of guidelines and educational programs aiming to reduce PIM use in the elderly. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 536 | _ | _ | |a 345 - Population Studies and Genetics (POF3-345) |0 G:(DE-HGF)POF3-345 |c POF3-345 |f POF III |x 1 |
| 542 | _ | _ | |i 2018-09-19 |2 Crossref |u http://creativecommons.org/licenses/by/4.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Aged, 80 and over |2 MeSH |
| 650 | _ | 2 | |a Drug-Related Side Effects and Adverse Reactions: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Drug-Related Side Effects and Adverse Reactions: prevention & control |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a General Practitioners: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Inappropriate Prescribing: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Interviews as Topic |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Patients: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Potentially Inappropriate Medication List: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Qualitative Research |2 MeSH |
| 650 | _ | 2 | |a Risk Assessment: methods |2 MeSH |
| 650 | _ | 2 | |a Risk Assessment: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Risk Factors |2 MeSH |
| 700 | 1 | _ | |a Pohontsch, Nadine Janis |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Scherer, Martin |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Löffler, Antje |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Luck, Tobias |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Riedel-Heller, Steffi G |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Maier, Wolfgang |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Parker, Debora |0 P:(DE-2719)2810865 |b 7 |
| 700 | 1 | _ | |a Haenisch, Britta |0 P:(DE-2719)2810511 |b 8 |
| 700 | 1 | _ | |a Jessen, Frank |0 P:(DE-2719)2000032 |b 9 |e Last author |
| 773 | 1 | 8 | |a 10.1371/journal.pone.0202068 |b : Public Library of Science (PLoS), 2018-09-19 |n 9 |p e0202068 |3 journal-article |2 Crossref |t PLOS ONE |v 13 |y 2018 |x 1932-6203 |
| 773 | _ | _ | |a 10.1371/journal.pone.0202068 |g Vol. 13, no. 9, p. e0202068 - |0 PERI:(DE-600)2267670-3 |n 9 |q 13:9 |t PLOS ONE |v 13 |y 2018 |x 1932-6203 |
| 856 | 4 | _ | |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202068 |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145513 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140211/files/5248.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140211/files/5248.gif?subformat=icon |x icon |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140211/files/5248.jpg?subformat=icon-1440 |x icon-1440 |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140211/files/5248.jpg?subformat=icon-180 |x icon-180 |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140211/files/5248.jpg?subformat=icon-640 |x icon-640 |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140211/files/5248.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:140211 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2810865 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2810511 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2000032 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |2 G:(DE-HGF)POF3-300 |v Clinical and Health Care Research |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |2 G:(DE-HGF)POF3-300 |v Population Studies and Genetics |x 1 |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b PLOS ONE : 2021 |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2022-04-12T10:14:32Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2022-04-12T10:14:32Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2022-04-12T10:14:32Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-16 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2022-11-16 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2022-11-16 |
| 920 | 1 | _ | |0 I:(DE-2719)1013010 |k AG Hänisch |l Pharmacoepidemiology in Neurodegenerative Disorders |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1011102 |k AG Jessen |l Patient studies cologne |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1013010 |
| 980 | _ | _ | |a I:(DE-2719)1011102 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1365-2125.2011.04010.x |2 Crossref |o 10.1111/j.1365-2125.2011.04010.x |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/bmj.d3514 |2 Crossref |o 10.1136/bmj.d3514 |
| 999 | C | 5 | |y 2010 |2 Crossref |o S Holt 2010 |
| 999 | C | 5 | |y 2012 |2 Crossref |o U Amann 2012 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1001/archinte.165.1.68 |2 Crossref |o 10.1001/archinte.165.1.68 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00406-010-0156-4 |2 Crossref |o 10.1007/s00406-010-0156-4 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/bmj.320.7233.484 |2 Crossref |o 10.1136/bmj.320.7233.484 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/1471-2318-12-46 |2 Crossref |o 10.1186/1471-2318-12-46 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/j.1532-5415.2008.01923.x |2 Crossref |o 10.1111/j.1532-5415.2008.01923.x |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/fampra/14.5.369 |2 Crossref |o 10.1093/fampra/14.5.369 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.pec.2008.08.019 |2 Crossref |o 10.1016/j.pec.2008.08.019 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1136/bmj.38551.410012.06 |2 Crossref |o 10.1136/bmj.38551.410012.06 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S0277-9536(99)00376-7 |2 Crossref |o 10.1016/S0277-9536(99)00376-7 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1111/acps.12129 |2 Crossref |o 10.1111/acps.12129 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/s12875-017-0595-3 |2 Crossref |o 10.1186/s12875-017-0595-3 |
| 999 | C | 5 | |y 2010 |2 Crossref |o P Mayring 2010 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s11606-007-0205-5 |2 Crossref |o 10.1007/s11606-007-0205-5 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s11606-006-0021-3 |2 Crossref |o 10.1007/s11606-006-0021-3 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/1471-2296-3-9 |2 Crossref |o 10.1186/1471-2296-3-9 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.jemermed.2016.05.035 |2 Crossref |o 10.1016/j.jemermed.2016.05.035 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/fampra/cmm069 |2 Crossref |o 10.1093/fampra/cmm069 |
| 999 | C | 5 | |y 2006 |2 Crossref |o PM Verbeek-Heida 2006 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.amjopharm.2012.05.001 |2 Crossref |o 10.1016/j.amjopharm.2012.05.001 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/s12875-016-0482-3 |2 Crossref |o 10.1186/s12875-016-0482-3 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|